Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Thyroid Eye Disease News

1/21/2025
Clinical TrialCornealDry EyeGene TherapyGlaucomaNewsletterOcular CancerRetinaThyroid Eye Disease
Clinical Trial Updates for Ophthalmic Candidates, January 2025
Clinical Trial Updates for Ophthalmic Candidates, January 2025

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

9/27/2024
BreakingPharmaRegulationThyroid Eye Disease
Tepezza Receives Approval in Japan to Treat Active Thyroid Eye Disease
Tepezza Receives Approval in Japan to Treat Active Thyroid Eye Disease

Amgen reported Sept. 24 that Tepezza had gained approval in Japan for the treatment of active or high clinical activity score thyroid eye disease (TED). The Thousand Oaks, California, company said ...

8/23/2024
BreakingClinical TrialIndustryThyroid Eye Disease
Acelyrin Shifts Pipeline to Focus on TED Candidate, Lays Off About 40 Workers
Acelyrin Shifts Pipeline to Focus on TED Candidate, Lays Off About 40 Workers

Acelyrin reported Aug. 13 that it would reduce its workforce and shift its pipeline strategy to prioritize lonigutamab, its candidate for thyroid eye disease (TED). The announcement came amid posit...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more